The US Food and Drug Administration has allowed the use of chloroquine and hydroxychloroquine as a treatment for the emerging coronavirus, but only in hospitals, which are two anti-malarial drugs that US President Donald Trump has high hopes for.
The US health authorities have warned residents not to treat themselves at home, after a resident of Arizona (southwest) died after ingesting chloroquine phosphate to clean aquariums.
The US Department of Health confirmed in a statement that the Food and Drug Administration gave the green light for “doctors to distribute and prescribe these treatments to adolescent and adult patients with Covid 19 who are treated in hospitals, appropriately, when clinical trials are not available or possible.”
On March 24, the US President praised this drug, saying, “There is a real chance that it will have a tremendous impact, which will be a gift from God if he succeeds.”
French doctor Didier Roulette defends this drug and presented studies on it that did not completely convince the scientific community.
The National Institute of Health and the Department of Biomedical Research and Development in the United States are working on clinical tests for treatments.
A protocol-based test prepared by Professor Raoult, which combines hydroxychloroquine with azithromycin (an antibiotic), will be launched in New York.
The United States has recorded more than 140,000 infections and 2,489 deaths from the virus, according to Johns Hopkins University.